AstraZeneca (NYSE: AZN) ranks as one of the top big drugmakers in terms of stock performance so far this year. That's not surprising, considering the company's solid quarterly updates and the positive publicity that it's garnered for its coronavirus vaccine program.
But is AstraZeneca stock a buy now? My answer is a resounding "yes." Here are three key reasons why.
Image source: Getty Images.
Source Fool.com